Summary: Obstructive sleep apnea (OSA) is increasingly recognized as a contributor to measurable memory decline. A new review of human and animal studies links OSA—especially its hallmark features of intermittent hypoxia and sleep fragmentation—to processes that damage brain health and reduce memory performance, particularly visual and verbal working memory.
The review highlights a clear relationship between disease burden and cognitive outcome: greater OSA severity and longer duration are associated with worse memory function. Biomarkers such as the Oxygen Desaturation Index (ODI) correlate with the degree of impairment. Although continuous positive airway pressure (CPAP) remains the primary treatment for protecting cognition, the authors call for improved diagnostics and additional therapies to fully address OSA-related memory decline.
Key facts
- Biological injury: OSA-related intermittent hypoxia and sleep fragmentation trigger neuroinflammation, oxidative stress, neuronal injury, and synaptic dysfunction.
- Cognitive correlation: Memory deficits—especially in working memory of visual and verbal information—track with OSA severity and duration.
- Treatment and gaps: CPAP can significantly reduce memory problems for many patients, but complementary diagnostics and new therapeutic approaches are needed to fully protect cognition.
Source: Marshall University
Overview: Obstructive sleep apnea (OSA), long associated with cardiovascular and metabolic disease, also has a substantial and underappreciated impact on memory and cognitive health. In a comprehensive review published in Sleep Medicine Reviews, researchers synthesize findings from clinical and preclinical studies to characterize how OSA produces memory impairments, which cognitive domains are most affected, and what treatments or diagnostics might improve outcomes.
The authors report consistent evidence that people with OSA frequently experience declines in memory, with visual and verbal working memory among the most affected domains. Animal models and human studies converge on common mechanisms: repeated drops in blood oxygen (intermittent hypoxia) and disrupted sleep architecture (sleep fragmentation) set off molecular and cellular cascades that harm the brain.
Specifically, the review highlights several interrelated biological processes that likely mediate memory impairment in OSA: neuroinflammation, oxidative stress, direct neuronal injury, disrupted synaptic plasticity, and impairment of the blood-brain barrier. These processes can compromise the neural circuits that support learning and memory, producing deficits that clinicians and patients can detect on cognitive testing.
Clinical measures of disease burden, such as the Oxygen Desaturation Index (ODI), show strong correlations with cognitive performance, suggesting these biomarkers may be useful for predicting risk and monitoring progression. The authors emphasize that early detection of brain changes using imaging, EEG patterns, and circulating biomarkers could enable earlier intervention before irreversible damage occurs.
Therapeutically, continuous positive airway pressure (CPAP) remains the most consistently effective intervention to protect cognitive function in OSA patients. Evidence indicates that CPAP can attenuate or reverse some memory deficits, particularly when treatment is started early and adhered to consistently. Still, CPAP does not fully restore cognition for all patients, and the review calls for rigorous evaluation of emerging treatments that target inflammatory pathways, oxidative stress, or other mechanisms implicated in OSA-related brain injury.
Looking forward, the authors identify promising avenues for research. They highlight the potential contributions of the gut-brain axis, genetic susceptibility, and epigenetic changes to individual differences in vulnerability to memory decline. The team suggests that multidimensional clinical profiling—integrating physiological metrics, biomarker data, genetic and epigenetic information, and cognitive testing—could support precision medicine approaches to identify patients at highest risk and tailor treatments to their specific biological profiles.
The review was co-authored by Drs. Xiaoman Zhang, Huajun Xu, and Shankai Yin from Shanghai Jiao Tong University School of Medicine, together with Drs. David Gozal and Abdelnaby Khalyfa of Marshall University. Dr. Zhang completed a six-month research scholar program in Dr. Khalyfa’s laboratory at Marshall University, where the collaborative review was developed.
Funding: The work was supported by the Ministry of Science and Technology of the People’s Republic of China (STI2030-Major Projects 2021ZD0201900), the U.S. National Institutes of Health (HL166617, HL169266), and the Joan C. Edwards School of Medicine at Marshall University.
About this sleep apnea and memory research news
Author: Sheanna Spence
Source: Marshall University
Contact: Sheanna Spence – Marshall University
Image credit: Neuroscience News
Original research: Open access. Title: “Obstructive sleep apnea and memory impairments: Clinical characterization, treatment strategies, and mechanisms” by Xiaoman Zhang et al. DOI: 10.1016/j.smrv.2025.102092
Abstract
Obstructive sleep apnea and memory impairments: Clinical characterization, treatment strategies, and mechanisms
Obstructive sleep apnea (OSA) is linked to dysfunction across cardiovascular, metabolic, and neurological systems. Despite this, the precise relationship between OSA and memory impairment, the effects of different interventions, and the mechanistic pathways remain incompletely understood.
This review synthesizes recent advances in clinical characterization, treatment strategies, and mechanistic insights into OSA-induced memory impairments. Patients with OSA may show significant declines in memory, including deficits in working memory for visual and verbal information.
Mechanisms are complex and multifactorial: exposures to intermittent hypoxia and sleep fragmentation are associated with neuroinflammation, oxidative stress, neuronal damage, altered synaptic plasticity, and blood-brain barrier dysfunction—processes likely contributing to learning and memory deficits.
Continuous positive airway pressure treatment can provide substantial relief from memory impairment for many OSA patients, but additional therapies are under investigation and require rigorous testing for cognitive benefit. Clinically, more reliable and objective diagnostic tools are needed for accurate detection and characterization of cognitive impairments in OSA.
Emerging areas—such as gut-brain interactions, genetic and epigenetic influences, and clinical phenotyping—offer promising directions for future research. Detailed phenotypic clustering and precision medicine approaches may ultimately improve prediction, prevention, and individualized treatment of OSA-related memory deficits.